Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Avanir Pharmaceuticals
Avanir Pharmaceuticals
(AVNR)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Nuedexta
Dextromethorphan
,
Quinidine
2010-10-29
2023-2040
Neurobehavioral manifestations
,
Cough
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Dextromethorphan
healthy volunteers/patients
,
schizophrenia
,
treatment-resistant depressive disorder
,
dyskinesias
,
multiple sclerosis
,
neuralgia
,
migraine disorders
,
parkinson disease
,
pain
,
diabetic neuropathies
,
amyotrophic lateral sclerosis
,
pseudobulbar palsy
,
dementia
,
alzheimer disease
,
stroke
,
traumatic brain injuries
Quinidine gluconate
healthy volunteers/patients
,
treatment-resistant depressive disorder
,
dyskinesias
,
neuralgia
,
impulse control disruptive and conduct disorders
,
migraine disorders
,
schizophrenia
,
parkinson disease
,
multiple sclerosis
,
pain
,
diabetic neuropathies
,
amyotrophic lateral sclerosis
,
dementia
,
pseudobulbar palsy
,
alzheimer disease
,
stroke
,
traumatic brain injuries
Quinidine polygalacturonate
healthy volunteers/patients
,
treatment-resistant depressive disorder
,
dyskinesias
,
neuralgia
,
impulse control disruptive and conduct disorders
,
migraine disorders
,
schizophrenia
,
parkinson disease
,
multiple sclerosis
,
pain
,
diabetic neuropathies
,
amyotrophic lateral sclerosis
,
dementia
,
pseudobulbar palsy
,
alzheimer disease
,
stroke
,
traumatic brain injuries
Quinidine
healthy volunteers/patients
,
treatment-resistant depressive disorder
,
dyskinesias
,
neuralgia
,
impulse control disruptive and conduct disorders
,
migraine disorders
,
schizophrenia
,
parkinson disease
,
multiple sclerosis
,
pain
,
diabetic neuropathies
,
amyotrophic lateral sclerosis
,
dementia
,
pseudobulbar palsy
,
alzheimer disease
,
stroke
,
traumatic brain injuries
Alfacalcidol
parkinson disease
,
dyskinesias
,
migraine disorders
Ubidecarenone
stroke
,
traumatic brain injuries
,
dementia
,
pseudobulbar palsy
Neurodex
pain
,
diabetic neuropathies
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use